Heart Failure: Difference between revisions

Heart Failure (view source)

No change in size , 19 January 2012

401

edits

@@ Line 264: / Line 264: @@
 Aldosterone antagonists
-Adding this drug to therapy is suggested for patients with severe symptomatic (NYHA class III or IV, refer to table 2) HF and an LVEF < 35%. (Class I recommendation, level of evidence B) Contraindications:
+Adding this drug to therapy is suggested for patients with severe symptomatic (NYHA class III or IV, refer to Table 2) HF and an LVEF < 35%. (Class I recommendation, level of evidence B) Contraindications:
 * Serum potassium concentration > 5.0 mmol/L
 * Serum creatine > 220 µmol/L